These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17397355)
1. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus. Sun A; Chia JS; Wang JT; Chiang CP Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355 [TBL] [Abstract][Full Text] [Related]
2. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations. Sun A; Wang JT; Chia JS; Chiang CP J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742 [TBL] [Abstract][Full Text] [Related]
3. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus. Sun A; Wang JT; Chia JS; Chiang CP Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980 [TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. Sun A; Chia JS; Chang YF; Chiang CP J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322 [TBL] [Abstract][Full Text] [Related]
5. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus. Lin HP; Wang YP; Chia JS; Sun A J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152 [TBL] [Abstract][Full Text] [Related]
6. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus. Wu KM; Wang YP; Lin HP; Chen HM; Chia JS; Sun A J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020 [TBL] [Abstract][Full Text] [Related]
7. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus. Sun A; Chiang CP J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157 [TBL] [Abstract][Full Text] [Related]
8. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus. Lin HP; Wang YP; Chia JS; Sun A J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. Sklavounou-Andrikopoulou A; Chrysomali E; Iakovou M; Garinis GA; Karameris A J Oral Pathol Med; 2004 Aug; 33(7):386-90. PubMed ID: 15250829 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression in oral lichen planus. Zhou ZT; Wei BJ; Shi P J Oral Pathol Med; 2008 Feb; 37(2):94-8. PubMed ID: 18197854 [TBL] [Abstract][Full Text] [Related]
11. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Pezelj-Ribaric S; Prso IB; Abram M; Glazar I; Brumini G; Simunovic-Soskic M Mediators Inflamm; 2004 Apr; 13(2):131-3. PubMed ID: 15203556 [TBL] [Abstract][Full Text] [Related]
12. Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus. Chang JY; Chiang CP; Hsiao CK; Sun A J Oral Pathol Med; 2009 Jan; 38(1):48-54. PubMed ID: 18764857 [TBL] [Abstract][Full Text] [Related]
13. A new concept for the pathogenesis and treatment strategies for oral lichen planus. Zahran FM; el-Arab AE; Raafat I Egypt Dent J; 1995 Oct; 41(4):1363-6. PubMed ID: 9497682 [TBL] [Abstract][Full Text] [Related]
14. Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus. Lin HP; Wang YP; Chia JS; Chiang CP; Sun A Oral Dis; 2011 Jan; 17(1):95-101. PubMed ID: 20659263 [TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Rhodus NL; Cheng B; Bowles W; Myers S; Miller L; Ondrey F Oral Dis; 2006 Mar; 12(2):112-6. PubMed ID: 16476030 [TBL] [Abstract][Full Text] [Related]
16. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease. Sun A; Wang YP; Chia JS; Liu BY; Chiang CP J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815 [TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations. Sun A; Chang YF; Chia JS; Chiang CP J Oral Pathol Med; 2004 Mar; 33(3):133-9. PubMed ID: 15128054 [TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study. Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310 [TBL] [Abstract][Full Text] [Related]
19. Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone. Kuo RC; Lin HP; Sun A; Wang YP J Formos Med Assoc; 2013 Apr; 112(4):216-20. PubMed ID: 23537868 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of clinical data and immuno-modulating treatment of patients with oral lichen planus]. Kövesi G Fogorv Sz; 2001 Feb; 94(1):9-14. PubMed ID: 11262802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]